Pacira BioSciences Balance Sheet Health
Financial Health criteria checks 5/6
Pacira BioSciences has a total shareholder equity of $870.1M and total debt of $522.4M, which brings its debt-to-equity ratio to 60%. Its total assets and total liabilities are $1.6B and $704.3M respectively. Pacira BioSciences's EBIT is $87.3M making its interest coverage ratio 9.9. It has cash and short-term investments of $278.6M.
Key information
60.0%
Debt to equity ratio
US$522.44m
Debt
Interest coverage ratio | 9.9x |
Cash | US$278.58m |
Equity | US$870.13m |
Total liabilities | US$704.26m |
Total assets | US$1.57b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 82P's short term assets ($510.0M) exceed its short term liabilities ($97.4M).
Long Term Liabilities: 82P's short term assets ($510.0M) do not cover its long term liabilities ($606.9M).
Debt to Equity History and Analysis
Debt Level: 82P's net debt to equity ratio (28%) is considered satisfactory.
Reducing Debt: 82P's debt to equity ratio has reduced from 90.6% to 60% over the past 5 years.
Debt Coverage: 82P's debt is well covered by operating cash flow (29.6%).
Interest Coverage: 82P's interest payments on its debt are well covered by EBIT (9.9x coverage).